The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Unconventional T Cell Targets for Cancer Immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Andrews, D. M., Sullivan, L. C., Baschuk, N., Chan, C. J., Berry, R., Cotterell, C. L., Lin, J., Halse, H. M., Watt, S. V., Poursine‐Laurent, J., et al. (2012) · Nature Immunology · doi:10.1038/ni.2468 · Cited by 70
Self-citationNicol, A. J., Tazbirkova, A., & Nieda, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3105 · Cited by 70
Renukaradhya, G. J., Sriram, V., Du, W., Gervay‐Hague, J., Kaer, L. V., & Brutkiewicz, R. R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21764 · Cited by 69
The molecular bases of δ/αβ T cell–mediated antigen recognition
Pellicci, D. G., Uldrich, A. P., Nours, J. L., Ross, F. J., Chabrol, E., Eckle, S. B. G., de Boer, R., Lim, R. T., McPherson, K., Besra, G. S., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20141764 · Cited by 68
Self-citationNagato, K., Motohashi, S., Ishibashi, F., Okita, K., Yamasaki, K., Moriya, Y., Hoshino, H., Yoshida, S., Hanaoka, H., Fujii, S., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9697-9 · Cited by 67
High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis
Benevolo, M., Mottolese, M., Tremante, E., Rollo, F., Diodoro, M. G., Ercolani, C., Sperduti, I., Monaco, E. L., Cosimelli, M., & Giacomini, P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-184 · Cited by 66
Park, J., Wu, D., Prendes, M. J., Lu, S. X., Ragupathi, G., Schrantz, N., & Chapman, P. B. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02760.x · Cited by 65
Stanton, T. H., Calkins, C. E., Jandinski, J. J., Schendel, D. J., Stutman, O., Cantor, H., & Boyse, E. A. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.4.963 · Cited by 65
The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation
Shobu, T., Sageshima, N., Tokui, H., Omura, M., Saito, K., Nagatsuka, Y., Nakanishi, M., Hayashi, Y., Hatake, K., & Ishitani, A. (2006) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2006.02.001 · Cited by 63
Role of γδ T Cells in α-Galactosylceramide–Mediated Immunity
Paget, C., Chow, M. T., Duret, H., Mattarollo, S. R., & Smyth, M. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103582 · Cited by 62
Structural determination of lipid antigens captured at the CD1d–T-cell receptor interface
Brennan, P. J., Cheng, T., Pellicci, D. G., Watts, G. F. M., Veerapen, N., Young, D. C., Rossjohn, J., Besra, G. S., Godfrey, D. I., Brenner, M. B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705882114 · Cited by 61
Self-citationNKT TCR Recognition of CD1d-α- C -Galactosylceramide
Patel, O., Cameron, G., Pellicci, D. G., Liu, Z., Byun, H., Beddoe, T., McCluskey, J., Franck, R. W., Castaño, A. R., Harrak, Y., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100794 · Cited by 59
Self-citationAoki, T., Matsushita, H., Hoshikawa, M., Hasegawa, K., Kokudo, N., & Kakimi, K. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.01.002 · Cited by 59
Gasser, O., SHARPLES, K. J., Barrow, C., Williams, G. M., Bauer, E., Wood, C. E., Mester, B., Dzhelali, M., Caygill, G., Jones, J., et al. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2085-9 · Cited by 58
A molecular basis of human T cell receptor autoreactivity toward self-phospholipids
Shahine, A., Rhijn, I. V., Cheng, T., Iwany, S. K., Gras, S., Moody, D. B., & Rossjohn, J. (2017) · Science Immunology · doi:10.1126/sciimmunol.aao1384 · Cited by 58
Self-citationEfficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
Nitcheu-Tefit, J., Crabé, S., Orlandini, B., Nell, H., Bendelac, A. S., Deng, S., Savage, P. B., Teyton, L., & Serra, V. A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.070 · Cited by 56
Atypical natural killer T-cell receptor recognition of CD1d–lipid antigens
Nours, J. L., Praveena, T., Pellicci, D. G., Gherardin, N. A., Ross, F. J., Lim, R. T., Besra, G. S., Keshipeddy, S. K., Richardson, S. K., Howell, A. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms10570 · Cited by 55
Self-citationDelicate Balance among Three Types of T Cells in Concurrent Regulation of Tumor Immunity
Izhak, L., Ambrosino, E., Kato, S., Parish, S. T., O’Konek, J. J., Weber, H., Xia, Z., Venzon, D. J., Berzofsky, J. A., & Terabe, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2567 · Cited by 54
Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity
O’Konek, J. J., Illarionov, P. A., Khursigara, D. S., Ambrosino, E., Izhak, L., Castillo, B. F., Raju, R., Khalili, M., Kim, H., Howell, A. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42314 · Cited by 53
Clinical implication of human leukocyte antigen ( HLA )‐ F expression in breast cancer
Harada, A., Ishigami, S., Kijima, Y., Nakajo, A., Arigami, T., Kurahara, H., Kita, Y., Yoshinaka, H., & Natsugoe, S. (2015) · Pathology International · doi:10.1111/pin.12343 · Cited by 51
Cui, J., Li, L., Wang, C., Jin, H., Cheng, Y., Wang, Y., Li, D., Tian, H., Niu, C. S., Wang, G., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.03.605 · Cited by 51
Versluis, M., Marchal, S., Plat, A., de Bock, G. H., van Hall, T., de Bruyn, M., Hollema, H., & Nijman, H. W. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.008 · Cited by 51
Chiang, E. Y., Henson, M., & Stroynowski, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2200 · Cited by 46
Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection
Aspeslagh, S., Nemčovič, M., Pauwels, N., Venken, K., Wang, J., Calenbergh, S. V., Zajonc, D. M., & Elewaut, D. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203134 · Cited by 45
Differential surface phenotype and context‐dependent reactivity of functionally diverse NKT cells
Cameron, G., & Godfrey, D. I. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12034 · Cited by 43
Self-citationThe nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects
Oliveira, C., van Veelen, P. V., Querido, B. J., de Ru, A. H., Sluijter, M., Laban, S., Drijfhout, J., van der Burg, S., Offringa, R., & van Hall, T. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.2009142922610c · Cited by 42
Wun, K. S., Ross, F. J., Patel, O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.412320 · Cited by 40
alpha /beta - and gamma /delta TCR+ lymphocyte infiltration in necrotising choroidal melanomas
Bialasiewicz, A. A., Ma, J., & Richard, G. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.9.1069 · Cited by 39
Joly, E., & Rouillon, V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-2 · Cited by 35
Catamo, E., Zupin, L., Crovella, S., Celsi, F., & Segat, L. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.09.019 · Cited by 34
Kerzerho, J., Yu, E. D., Barra, C., Alari‐Pahissa, E., Girardi, E., Harrak, Y., Lauzurica, P., Llebaria, A., Zajonc, D. M., Akbari, O., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103049 · Cited by 34
Mutation of the Traj18 gene segment using TALENs to generate Natural Killer T cell deficient mice
Zhang, J., Bedel, R., Krovi, S. H., Tuttle, K. D., Zhang, B., Gross, J., Gapin, L., & Matsuda, J. L. (2016) · Scientific Reports · doi:10.1038/srep27375 · Cited by 34
Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages
Kirana, C., Ruszkiewicz, A. R., Stubbs, R. S., Hardingham, J. E., Hewett, P. J., Maddern, G. J., & Hauben, E. (2017) · International Journal of Cancer · doi:10.1002/ijc.30667 · Cited by 34
Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins
Speir, M., Authier-Hall, A., Brooks, C., Farrand, K. J., Compton, B. J., Anderson, R. J., Heiser, A., Osmond, T. L., Tang, C., Berzofsky, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14690-5 · Cited by 34
Li, X., Shiratsuchi, T., Chen, G., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901021 · Cited by 33
Bagchi, S., Li, S., & Wang, C.-R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1213932 · Cited by 33
Questionable Relevance of γδ T Lymphocytes in Renal Cell Carcinoma
Inman, B. A., Frigola, X., Harris, K. J., Kuntz, S. M., Lohse, C. M., Leibovich, B. C., & Kwon, E. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3578 · Cited by 30
Polyclonal Expansion of NKG2C+ NK Cells in TAP-Deficient Patients
Béziat, V., Sleiman, M., Goodridge, J. P., Kaarbø, M., Liu, L. L., Rollag, H., Ljunggren, H., Zimmer, J., & Malmberg, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00507 · Cited by 28
iNKT Cells Suppress the CD8+ T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
Bjordahl, R., Gapin, L., Marrack, P., & Refaeli, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042635 · Cited by 28
Tumor border sharpness correlates with HLA-G expression in low-grade gliomas
Wang, Y., Fan, X., Li, H., Lin, Z., Bao, H., Li, S., Wang, L., Jiang, T., Yong Fan, A., & Jiang, T. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.02.013 · Cited by 27
Mucosal‐associated invariant T cell receptor recognition of small molecules presented by MR 1
Awad, W., Nours, J. L., Kjer‐Nielsen, L., McCluskey, J., & Rossjohn, J. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12017 · Cited by 27
Self-citationKammertoens, T., Qin, Z., Briesemeister, D., Bendelac, A. S., & Blankenstein, T. J. F. (2011) · International Journal of Cancer · doi:10.1002/ijc.27411 · Cited by 26
A Nonclassical MHC Class I Molecule Restricts CTL-Mediated Rejection of a Syngeneic Melanoma Tumor
Chiang, E. Y., & Stroynowski, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4394 · Cited by 24
Toia, F., Buccheri, S., Anfosso, A., Moschella, F., Dieli, F., Meraviglia, S., & Cordova, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149570 · Cited by 22
Li, J.-B., Ruan, Y.-Y., Hu, B., Dong, S.-S., Bi, T., Lin, A., & Yan, W. (2017) · Oncotarget · doi:10.18632/oncotarget.16457 · Cited by 20
Guillaume, N., & Marolleau, J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2012.12.021 · Cited by 11
Mouse models for studies of HLA-G functions in basic science and pre-clinical research.
Nguyen-Lefebvre, A. T., Ajith, A., Portik‐Dobos, V., Horuzsko, D. D., Mulloy, L., & Horuzsko, A. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.02.012 · Cited by 10
Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Cited by
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Self-citationHarnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
The biology and functional importance of MAIT cells
Godfrey, D. I., Koay, H.-F., McCluskey, J., & Gherardin, N. A. (2019) · Nature Immunology · doi:10.1038/s41590-019-0444-8 · Cited by 581
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Self-citation
Metadata
- Authors
- Godfrey, D. I., Le Nours, J., Andrews, D. M., Uldrich, A. P., & Rossjohn, J.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 48
- Issue
- 3
- Pages
- 453-473
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2791034815
- Cited by
- 314
- References
- 248
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.